Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOXYNE LIMITED AGM Information 2016

Nov 22, 2016

64594_rns_2016-11-22_011228f0-b7e4-4841-a2b3-e7be3523f135.pdf

AGM Information

Open in viewer

Opens in your device viewer

==> picture [596 x 55] intentionally omitted <==

----- Start of picture text ----- Suite 2508, Level 25, 31 Market St----- End of picture text -----

==> picture [596 x 56] intentionally omitted <==

----- Start of picture text ----- P: +61 2 9078 8180W: www.bioxyne.com----- End of picture text -----

23 November 2016

ASX ANNOUNCEMENT

Annual General Meeting – Amendment to Resolutions

The Annual General Meeting of Bioxyne Limited (ASX: BXN) will be held on Thursday 24 November at 12 noon at the Boardroom of RSM Australia Level 13, 60 Castlereagh Street, Sydney.

The Board advises that Resolution 4 of the Notice of Meeting lodged with the ASX on 24 October 2016 will not be put to the meeting, and will be dealt at a subsequent shareholders meeting.

Guy Robertson Company Secretary

==> picture [455 x 250] intentionally omitted <==

==> picture [455 x 32] intentionally omitted <==

About Bioxyne

Bioxyne Limited (ASX:BXN) is an Australian life sciences, health and medical technologies company (originated as VRI Biomedical Ltd in 2000) with a focus on immune health and immunotherapeutic products.

Bioxyne has a strategic investment in the consumer dietary supplements and functional foods markets through its proprietary probiotic, Lactobacillus fermentum PCC®. Bioxyne is a company creating value for consumers and investors by delivering safe and effective solutions.

Bioxyne’s focus is currently on the company’s probiotic business and proprietary product Lactobacillus fermentum PCC® which is supported by a manufacturing and distribution agreement with Chr. Hansen (Denmark) a global leader in the manufacturing of natural food additives and supplements products for the food, health, pharmaceutical and agriculture industries.

Bioxyne also has a distribution agreement with Nu‐Skin Enterprises (USA) a successful worldwide multilevel marketing company who pride themselves in offering only quality solutions to their customers.

Tony Ho Guy Robertson Non‐executive Chairman Chief Operating Officer Mob: +61 417 345 839 Mob: +61 407 983 270